Company Description
AVROBIO (NASDAQ: AVRO) is classified in the biological product (except diagnostic) manufacturing industry within the Biological Products, (no Disgnostic Substances) sector and carries a market capitalization of $62.9M, ranking #5,648 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for AVRO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AVROBIO (AVRO) stock last traded at $1.40. At a market capitalization of $62.9M, AVRO is classified as a micro-cap stock with approximately 44.9M shares outstanding.
AVRO Rankings
Latest News
AVROBIO has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, clinical trial, acquisition, earnings. View all AVRO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AVRO Company Profile & Sector Positioning
AVROBIO (AVRO) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.